NYSE:PRGO

Perrigo Stock Forecast, Price & News

$46.15
-0.08 (-0.17 %)
(As of 07/27/2021 09:45 AM ET)
Add
Compare
Today's Range
$46.06
$46.23
50-Day Range
$44.62
$48.87
52-Week Range
$38.20
$57.03
Volume1,192 shs
Average Volume1.03 million shs
Market Capitalization$6.16 billion
P/E RatioN/A
Dividend Yield2.07%
Beta1.19
30 days | 90 days | 365 days | Advanced Chart
Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.


Perrigo logo

About Perrigo

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, and Dr. Fresh. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations in the United States, as well as pharmaceutical and diagnostic products in Israel. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.01 out of 5 stars

Medical Sector

157th out of 4,434 stocks

Pharmaceutical Preparations Industry

67th out of 1,738 stocks

Analyst Opinion: 2.1Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Perrigo (NYSE:PRGO) Frequently Asked Questions

Is Perrigo a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Perrigo stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PRGO, but not buy additional shares or sell existing shares.
View analyst ratings for Perrigo
or view top-rated stocks.

What stocks does MarketBeat like better than Perrigo?

Wall Street analysts have given Perrigo a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Perrigo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Perrigo?

Perrigo saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 5,060,000 shares, a decrease of 24.1% from the May 31st total of 6,670,000 shares. Based on an average daily trading volume, of 1,070,000 shares, the days-to-cover ratio is presently 4.7 days. Currently, 3.8% of the company's stock are sold short.
View Perrigo's Short Interest
.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Perrigo
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) announced its earnings results on Monday, May, 10th. The company reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.57 by $0.07. The company had revenue of $1.01 billion for the quarter, compared to analysts' expectations of $1.03 billion. Perrigo had a positive trailing twelve-month return on equity of 8.06% and a negative net margin of 4.88%. The firm's revenue for the quarter was down 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 EPS.
View Perrigo's earnings history
.

How has Perrigo's stock been impacted by Coronavirus?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PRGO stock has increased by 0.2% and is now trading at $46.15.
View which stocks have been most impacted by COVID-19
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Monday, April 19th. Shareholders of record on Friday, June 4th will be paid a dividend of $0.24 per share on Tuesday, June 22nd. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend is Thursday, June 3rd.
View Perrigo's dividend history
.

Is Perrigo a good dividend stock?

Perrigo pays an annual dividend of $0.96 per share and currently has a dividend yield of 2.07%. Perrigo does not yet have a strong track record of dividend growth. The dividend payout ratio of Perrigo is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Perrigo will have a dividend payout ratio of 33.10% next year. This indicates that Perrigo will be able to sustain or increase its dividend.
View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share (EPS) guidance of $2.500-2.700 for the period, compared to the Thomson Reuters consensus estimate of $2.620. The company issued revenue guidance of -.

What price target have analysts set for PRGO?

4 equities research analysts have issued 1-year price targets for Perrigo's shares. Their forecasts range from $45.00 to $63.00. On average, they anticipate Perrigo's share price to reach $52.00 in the next year. This suggests a possible upside of 12.7% from the stock's current price.
View analysts' price targets for Perrigo
or view top-rated stocks among Wall Street analysts.

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 61, Pay $3.22M)
  • Mr. Raymond P. Silcock, CFO, Principal Accounting Officer & Exec. VP (Age 70, Pay $1.36M)
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 61, Pay $1.1M)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 59, Pay $1.12M)
  • Mr. Richard S. Sorota, Exec. VP & Pres of Consumer Self-Care Americas (Age 58, Pay $1.1M)
  • Mr. Ronald C. Janish, Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain (Age 55)
  • Mr. Shannon Hukill, Sr. Director of Technical Operations
  • Mr. Thomas M. Farrington, Chief Information Officer & Exec. VP (Age 64)
  • Mr. James E. Dillard III, Exec. VP & Chief Scientific Officer (Age 57)
  • Mr. Bradley Joseph, VP of Global Investor Relations & Corp. Communications

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo CEO Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among Perrigo's employees.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by many different retail and institutional investors. Top institutional investors include Harel Insurance Investments & Financial Services Ltd. (0.90%), Manning & Napier Group LLC (0.30%), TCW Group Inc. (0.02%), State of Alaska Department of Revenue (0.02%), Oregon Public Employees Retirement Fund (0.01%) and Cypress Capital Group (0.00%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Richard S Sorota, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo
.

Which major investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., State of Alaska Department of Revenue, and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for Perrigo
or view top insider-selling stocks.

Which major investors are buying Perrigo stock?

PRGO stock was bought by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Cypress Capital Group, and TCW Group Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Richard S Sorota, Svend Andersen, and Theodore R Samuels II.
View insider buying and selling activity for Perrigo
or or view top insider-buying stocks.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $46.15.

How much money does Perrigo make?

Perrigo has a market capitalization of $6.16 billion and generates $5.06 billion in revenue each year. The company earns $-162,600,000.00 in net income (profit) each year or $4.02 on an earnings per share basis.

How many employees does Perrigo have?

Perrigo employs 11,500 workers across the globe.

When was Perrigo founded?

Perrigo was founded in 1887.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

Where are Perrigo's headquarters?

Perrigo is headquartered at THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.